Evidence map›Paper›PMID 39833034›Full record

ReviewMedicine2025

Dexmedetomidine-associated hypothermia in critical trauma: A case report and literature analysis.

Se Heon Kim, Younghoon Sul, Jin Bong Ye, Jin Young Lee, Jin Suk Lee

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Ketamine enhancement of dexmedetomidine attenuation of methamphetamine-induced agitation in rats.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  3. The locus coeruleus maintains core body temperature and protects against hypothermia during dexmedetomidine-induced sedation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Se Heon KimDepartment of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Republic of Korea.ORCID 0000-0002-1864-4096
Younghoon SulDepartment of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Republic of Korea.ORCID 0000-0003-3184-3396
Jin Bong YeDepartment of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Republic of Korea.ORCID 0000-0002-5597-4502
Jin Young LeeDepartment of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Republic of Korea.ORCID 0000-0002-4629-0934
Jin Suk LeeDepartment of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Republic of Korea.ORCID 0000-0002-6694-4683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleHypothermia, defined as a core body temperature below 35°C, is a common and serious complication in severe trauma patients, often worsened by hemorrhage and medical interventions. Dexmedetomidine, an α2-adrenergic agonist used for sedation in intensive care units, has known thermoregulatory effects; however, its association with hypothermia in trauma patients remains insufficiently explored. PATIENT CONCERNS: A 40-year-old male with severe polytrauma from a motor vehicle accident presented in distress, with hypotension, tachycardia, and a baseline temperature of 35.8°C. Despite effective management, he developed profound hypothermia, with a recorded temperature dropping below 34.0°C after switching from midazolam to dexmedetomidine for sedation. DIAGNOSES: The patient had multiple bilateral rib fractures, a right-sided pneumothorax, and grade 3 liver and grade 5 splenic injuries, along with orthopedic fractures. His Injury Severity Score signified critical trauma, increasing the risk of complications like hypothermia.

interventionsFollowing stabilization, dexmedetomidine was administered for sedation. Continuous warming interventions were initiated to address hypothermia; however, the temperature continued to decline. Suspecting dexmedetomidine's contribution, its administration was discontinued. OUTCOMES: After stopping dexmedetomidine, the patient's temperature gradually recovered to 36.8°C within 5 hours. He demonstrated improved consciousness and stable vital signs, subsequently undergoing 2 successful orthopedic surgeries and discharging without further hypothermia-related issues. LESSONS: This case highlights dexmedetomidine's potential to induce hypothermia in critically ill trauma patients. It stresses the importance of careful temperature monitoring and proactive thermoregulation during sedative administration in intensive care. Further research is needed to explore the prevalence and mechanisms of dexmedetomidine-associated hypothermia in trauma populations.

Indexed as

Adrenergic alpha-2 Receptor AgonistsDexmedetomidineHypnotics and SedativesHypothermiaMultiple TraumaAccidents, TrafficAdultHumansMaleAdrenergic alpha-2 Receptor AgonistsDexmedetomidineHypnotics and Sedatives

Identifiers

PMID39833034
PMCPMC11749715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.